Zobrazeno 1 - 10 of 21 pro vyhledávání: '"H. Friccius-Quecke"'
1
AB0299 REAL-WORLD ASSESSMENT OF GP2015 (ETANERCEPT BIOSIMILAR, SDZ-ETN): AN INTERIM ANALYSIS OF DATA FROM THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE COMPACT STUDY
Autor: A. Askari, T. Kupka, F. Furlan, H. Kellner, S. Hachaichi, M. Schmalzing, H. Friccius-Quecke
Publikováno v: Annals of the Rheumatic Diseases. 79:1449.1-1449
Background:COMPACT is a non-interventional study to collect real-world evidence in European countries and Canada on effectiveness, safety and quality of life in rheumatoid arthritis (RA), ankylosing spondylitis or psoriatic arthritis patients (pts) t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53ba4fbebaae5600257dbff69cbb6d96
https://doi.org/10.1136/annrheumdis-2020-eular.1776
Zobrazit plný text záznamu
3
Effects of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) on proliferation and cytokine secretion of immune cells in malignant pleural effusion
Autor: Wolfgang Schuette, Horst Lindhofer, H. Friccius-Quecke, H. Friccius Quecke, Rainer Wiewrodt, Martin Sebastian, Alexander Schmittel, Philipp Kiewe, B. Mueller, M. Jaeger
Publikováno v: Journal of Clinical Oncology. 25:3046-3046
3046 Background: The trifunctional antibody catumaxomab specifically binds EpCAM+ tumor cells, CD3+ T lymphocytes and accessory cells via FcγR I/III. Thus the antibody induces tumor specific cell mediated cytotoxicity in vitro and in vivo. Following
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5c46f15ec1e6851fef5bfbf3c775786e
https://doi.org/10.1200/jco.2007.25.18_suppl.3046
Zobrazit plný text záznamu
5
Decrease of VEGF within malignant ascites during catumaxomab treatment: Results from a pivotal phase II/III study
Autor: A. Schoberth, B. Theissen, M. Jäger, J. Hess, H. Friccius-Quecke, Horst Lindhofer
Publikováno v: Journal of Clinical Oncology. 27:3029-3029
3029 Background: Treatment with the trifunctional anti-EpCAM x anti-CD3 antibody catumaxomab efficiently eliminates tumor cells from the peritoneal cavity (Jäger et al., ASCO 2007) and led to clinically relevant prolongation of puncture-free surviva
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c435ea06a836d335dc366b355aa8cf3
https://doi.org/10.1200/jco.2009.27.15_suppl.3029
Zobrazit plný text záznamu
7
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3): Results of a phase I/II study
Autor: Folker Schneller, Bernward Passlick, Alexander Schmittel, Martin Sebastian, G. Nilius, H. Friccius-Quecke, M. Jaeger, G. Hoffken, S. Lodziewski, Wolfgang Schuette
Publikováno v: Journal of Clinical Oncology. 24:2548-2548
2548 Background: The trifunctional antibody catumaxomab specifically binds EpCAM+ tumor cells, CD3+ T lymphocytes and accessory cells via the Fcγ RI/III. Thus the antibody induces tumor specific cell mediated cytotoxicity in vitro and in vivo. Its i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c7e26b24ec4a23b849e23e7be14ec713
https://doi.org/10.1200/jco.2006.24.18_suppl.2548
Zobrazit plný text záznamu
8
Treatment of non-small cell lung cancer (NSCLC) patients with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3): Results of a phase I/II study
Autor: Martin Sebastian, M. Jaeger, F. Kanniess, Bernward Passlick, Alexander Schmittel, Horst Lindhofer, Rainer Wiewrodt, H. Friccius-Quecke
Publikováno v: Journal of Clinical Oncology. 24:2540-2540
2540 Background: Catumaxomab is a trifunctional monoclonal antibody with binding specificities to human EpCAM, human CD3 and Fc gamma receptor I/III-positive accessory cells leading to induction of cell mediated, tumor specific cytotoxicity. As EpCAM
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41ada24382041038ca7b727f7fa672bc
https://doi.org/10.1200/jco.2006.24.18_suppl.2540
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje